Incyte to acquire North Carolina drug developer in deal valued at up to $1.36 billion
October 03, 2022 at 10:20 AM EDT
The deal involving an experimental skin disorder drug includes an upfront payment of $70 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |